19th Annual Non-Dilutive Funding Summit
The 19th Non-Dilutive Funding Summit brought together hundreds of life science industry leaders with representatives from some of the leading funding agencies including ARPA-H, SEED, NINDS, NHLBI, NIMHD, NCI and more, giving attendees the opportunity to learn more in-depth about what non-dilutive funding opportunities are available and relevant for their R&D directly from the funding agencies.
Additionally, the 2023 FreeMind Elite honorees from AmplifiDx, Sapience Therapeutics, Marker Therapeutics, and Vincere Biosciences took to the stage to present about their compies research and pipelines.
This free summit is hosted by the FreeMind Group. FreeMind helps companies secure non-dilutive funding for life science R&D and wins over $100 million each year for clients. Follow us on LinkedIn or get our newsletter for news about non-dilutive funding opportunities, announcements about conferences with the best partnering, and discounts for those conferences. The 20th Non-Dilutive Funding Summit will be January 8, 2025.
“Funding and Product Development Resources for Heart, Lung, Blood, and Sleep Technologies”
National Heart, Lung, and Blood Institute (NHLBI)
The National Heart, Lung, and Blood Institute (NHLBI) is one of the institutes within the United States National Institutes of Health (NIH) that is dedicated to research and education related to heart, lung, and blood disorders. NHLBI conducts research to better understand cardiovascular, pulmonary, and hematologic conditions, while also supporting clinical trials and public health initiatives. NHLBI plays a critical role in advancing knowledge about these disorders, promoting health lifestyles, and improving the diagnosis and treatment of heart, lung, and blood diseases.
Dr. Stephanie Davis
Small Business Program Coordinator, NHLBI
Stephanie received her B.S. in Biochemistry and Molecular Biology in 2012 from Florida Southern College. She received her M.S. in Medical Sciences (2015) and her Ph.D. in Molecular Pharmacology (2016) from the University of South Florida. Stephanie was a postdoctoral scholar at the University of Kentucky in the Department of Neurology. In addition to her postdoctoral appointment, she also interned part-time with the UK Office of Technology Commercialization from January to July 2019. Before joining the Innovation Office, Stephanie was selected for the 2019-2020 Executive Branch AAAS Science and Technology Policy Fellows Program, where she served as a Program Manager in the National Institute on Aging Office of Small Business Research. She has served as the National Heart Lung and Blood Institute Small Business Program Coordinator since December 2020.